FindTrial
Sign In

Feasibility and acceptability of a Virtual Clinical Pharmacy Service (VCPS) for elective orthopaedic inpatients in an Australian tertiary metropolitan hospital

Feasibility and acceptability of a Virtual Clinical Pharmacy Service (VCPS) for elective orthopaedic inpatients in an Australian tertiary metropolitan hospital

Status
Completed
Phases
Unknown
Study type
Interventional
Source
ANZCTR
Registry ID
ACTRN12621000983808
Enrollment
401
Registered
2021-07-26
Start date
2021-04-27
Completion date
2021-07-07
Last updated
2025-09-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Brief summary

We are doing a research project to evaluate the feasibility of a Virtual Clinical Pharmacy Service (VCPS) that is being delivered via video link to patients admitted to an elective orthopaedic ward at Royal Prince Alfred Hospital located in Sydney NSW. The aim is to explore if a service can be implemented, if it will detect potential medication errors and if it is acceptable by patients and hospital staff. Routine data collection from patients' electronic medical record will help to measure the success of the VCPS.

Interventions

This is a non-randomised feasibility study of Virtual Clinical Pharmacy Services at an elective orthopaedic ward at a tertiary metropolitan hospital. The Virtual Clinical Pharmacy Service will provide remote clinical support to patients, doctors and nurses using digital technologies including video-conference, the electronic medical record and electronic medicine management. The virtual pharmacist will provide services consistent with recognised standards of face to face clinical pharmacy from M

This is a non-randomised feasibility study of Virtual Clinical Pharmacy Services at an elective orthopaedic ward at a tertiary metropolitan hospital. The Virtual Clinical Pharmacy Service will provide remote clinical support to patients, doctors and nurses using digital technologies including video-conference, the electronic medical record and electronic medicine management. The virtual pharmacist will provide services consistent with recognised standards of face to face clinical pharmacy from Monday to Friday from 8am to 430pm for a 12 week trial period. The trial will be evaluated through routinely collected health data (service utilisation) and perceived patient and staff acceptability.

Sponsors

Western NSW Local Health District
Lead SponsorGovernment body

Study design

Allocation
Non-randomised trial
Intervention model
Single group
Primary purpose
Treatment
Masking
Open (masking not used)

Eligibility

Sex/Gender
All
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

Admitted elective orthopaedic inpatients. Doctors, nurses, pharmacists and other health professionals whom work at the study location.

Exclusion criteria

Outpatients

Outcome results

None listed

Source: ANZCTR · Data processed: Feb 4, 2026